These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2026490)

  • 21. Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
    Zidar BL; Baker LH; Rivkin SE; Balcerzak SP; Stephens RL
    Cancer Treat Rep; 1985 Sep; 69(9):1035-6. PubMed ID: 4028037
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase I trial of diaziquone (AZQ) plus GM-CSF.
    Hartmann LC; Ames MM; Reid JM; Richardson RL
    Invest New Drugs; 1995; 13(2):175-6. PubMed ID: 8617583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of diaziquone in untreated advanced gastric carcinoma. A Southwest Oncology Group Study.
    Pugh RP; Fleming T; Guy JT; Weick JK; Ward JH
    Am J Clin Oncol; 1989 Feb; 12(1):11-3. PubMed ID: 2912017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study of diaziquone in childhood leukemia: a report from the Children's Cancer Study Group.
    Ettinger LJ; Krailo M; Ruccione KS; Krivit W; Hammond GD
    Am J Pediatr Hematol Oncol; 1988; 10(1):18-22. PubMed ID: 3189713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II clinical trial of diaziquone in bronchogenic carcinoma.
    Chiuten DF; Umsawasdi T; Dhingra HM; Murphy WK; Spitzer G; Carr DT; Bodey GP; Valdivieso M
    Cancer Treat Rep; 1985; 69(7-8):921-2. PubMed ID: 4016800
    [No Abstract]   [Full Text] [Related]  

  • 26. Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors.
    Eagan RT; Dinapoli RP; Cascino TL; Scheithauer B; O'Neill BP; O'Fallon JR
    J Neurooncol; 1987; 5(4):309-14. PubMed ID: 3440875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of diaziquone in malignant mesothelioma.
    Eagan RT; Frytak S; Richardson RL; Creagan ET; Nichols WC
    Cancer Treat Rep; 1986 Mar; 70(3):429. PubMed ID: 3955559
    [No Abstract]   [Full Text] [Related]  

  • 28. A phase II trial of amonafide in patients with mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study.
    Asbury R; Blessing JA; Podczaski E; Ball H
    Am J Clin Oncol; 1998 Jun; 21(3):306-7. PubMed ID: 9626805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the Brain Tumor Study Group.
    Malkin MG; Green SB; Byar DP; Strike TA; Burger PC; Vogel FS; Pistenmaa DA; Mahaley MS; Ransohoff J; Shapiro WR
    J Neurooncol; 1994; 22(1):55-65. PubMed ID: 7714551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I-II diaziquone chemotherapy in brain tumors.
    Madajewicz S; Spaulding M; Bhimani S; Avellanosa A; DeLos Santos R; Perry A; Zeigler P; Kirshner J
    Cancer Treat Rep; 1984 Jun; 68(6):913-4. PubMed ID: 6733706
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report.
    Decker DA; Al Sarraf M; Kresge C; Austin D; Wilner HI
    J Neurooncol; 1985; 3(1):19-21. PubMed ID: 2987424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study Group.
    Ettinger LJ; Ru N; Krailo M; Ruccione KS; Krivit W; Hammond GD
    J Neurooncol; 1990 Aug; 9(1):69-76. PubMed ID: 2213117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Slayton RE; Blessing JA; Sutton GP; Homesley HD; Park R
    Cancer Treat Rep; 1986 Feb; 70(2):309-10. PubMed ID: 3948196
    [No Abstract]   [Full Text] [Related]  

  • 34. A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors.
    Chamberlain MC; Prados MD; Silver P; Levin VA
    J Neurooncol; 1988 Dec; 6(4):319-23. PubMed ID: 3221259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study.
    Thigpen JT; Blessing JA; Beecham J; Homesley H; Yordan E
    J Clin Oncol; 1991 Nov; 9(11):1962-6. PubMed ID: 1941054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma.
    Schold SC; Herndon JE; Burger PC; Halperin EC; Vick NA; Cairncross JG; Macdonald DR; Dropcho EJ; Morawetz R; Bigner DD
    J Clin Oncol; 1993 Jan; 11(1):77-83. PubMed ID: 8418246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II trial of diaziquone in patients with colon cancer.
    Neidhart JA; Erlichman C; Robert F; Velez-Garcia E; Bender JF; Grillo-López J
    Cancer Treat Rep; 1985 Feb; 69(2):215-7. PubMed ID: 3882229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II trial of diaziquone in advanced upper aerodigestive cancer.
    Creagan ET; Long HJ; Kvols LK; Edmonson JH; O'Fallon JR
    Cancer Treat Rep; 1985 Jan; 69(1):141. PubMed ID: 3967258
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II study of diaziquone in patients with advanced carcinoma of the lung.
    Frytak S; Eagan RT; Creagan ET; Nichols WC
    Cancer Treat Rep; 1984 Sep; 68(9):1193-4. PubMed ID: 6478455
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II clinical evaluation of AZQ in metastatic breast cancer.
    Yap HY; Bedikian AY; Schell FC; Blumenschein GR; Bodey GP
    Am J Clin Oncol; 1983 Feb; 6(1):31-3. PubMed ID: 6837505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.